Ulrika Andersson‐Hall

2.1k total citations · 1 hit paper
39 papers, 1.6k citations indexed

About

Ulrika Andersson‐Hall is a scholar working on Physiology, Obstetrics and Gynecology and Epidemiology. According to data from OpenAlex, Ulrika Andersson‐Hall has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 12 papers in Obstetrics and Gynecology and 9 papers in Epidemiology. Recurrent topics in Ulrika Andersson‐Hall's work include Gestational Diabetes Research and Management (12 papers), Adipose Tissue and Metabolism (8 papers) and Birth, Development, and Health (7 papers). Ulrika Andersson‐Hall is often cited by papers focused on Gestational Diabetes Research and Management (12 papers), Adipose Tissue and Metabolism (8 papers) and Birth, Development, and Health (7 papers). Ulrika Andersson‐Hall collaborates with scholars based in Sweden, United Kingdom and Denmark. Ulrika Andersson‐Hall's co-authors include Caroline R. Abbott, Caroline J. Small, K. L. Smith, David Carling, Stephen R. Bloom, Karin Filipsson, Angela Woods, Raymond A. Dwek, Terry D. Butters and Frances M. Platt and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Analytical Biochemistry.

In The Last Decade

Ulrika Andersson‐Hall

37 papers receiving 1.5k citations

Hit Papers

AMP-activated Protein Kinase Plays a Role in the Control ... 2004 2026 2011 2018 2004 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulrika Andersson‐Hall Sweden 18 775 592 379 274 237 39 1.6k
Márcio Alberto Torsoni Brazil 26 863 1.1× 518 0.9× 717 1.9× 216 0.8× 431 1.8× 81 2.1k
Miles D. Thompson Canada 28 381 0.5× 718 1.2× 126 0.3× 154 0.6× 227 1.0× 53 1.9k
William Abplanalp United States 19 353 0.5× 431 0.7× 230 0.6× 131 0.5× 171 0.7× 32 1.4k
Giovanni Ceccarini Italy 24 428 0.6× 484 0.8× 368 1.0× 187 0.7× 224 0.9× 73 1.8k
A. Kervran France 24 445 0.6× 464 0.8× 253 0.7× 731 2.7× 173 0.7× 64 2.0k
Fiorella Marcheselli Italy 19 583 0.8× 734 1.2× 523 1.4× 85 0.3× 108 0.5× 56 2.1k
Jianliang Chen United States 25 190 0.2× 493 0.8× 283 0.7× 234 0.9× 75 0.3× 59 1.4k
Elena Silvestri Italy 32 1.4k 1.8× 1.2k 2.0× 165 0.4× 159 0.6× 351 1.5× 85 2.9k
Sarah L. Gray Canada 22 929 1.2× 1.3k 2.2× 349 0.9× 363 1.3× 546 2.3× 42 2.7k
Sergio Rodríguez‐Cuenca United Kingdom 21 1.3k 1.6× 773 1.3× 199 0.5× 133 0.5× 601 2.5× 38 2.1k

Countries citing papers authored by Ulrika Andersson‐Hall

Since Specialization
Citations

This map shows the geographic impact of Ulrika Andersson‐Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrika Andersson‐Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrika Andersson‐Hall more than expected).

Fields of papers citing papers by Ulrika Andersson‐Hall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrika Andersson‐Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrika Andersson‐Hall. The network helps show where Ulrika Andersson‐Hall may publish in the future.

Co-authorship network of co-authors of Ulrika Andersson‐Hall

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrika Andersson‐Hall. A scholar is included among the top collaborators of Ulrika Andersson‐Hall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrika Andersson‐Hall. Ulrika Andersson‐Hall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chung, Heaseung Sophia, Manik Garg, Ventzislava A. Hristova, et al.. (2024). Longitudinal clinical and proteomic diabetes signatures in women with a history of postgestational diabetes. JCI Insight. 10(2).
2.
Andersson‐Hall, Ulrika, et al.. (2024). Glucose tolerance two years after gestational diabetes classified by old Swedish or new WHO diagnostic criteria. Diabetes Research and Clinical Practice. 216. 111831–111831.
3.
Fridolfsson, Jonatan, et al.. (2023). Validation of Oura ring energy expenditure and steps in laboratory and free-living. BMC Medical Research Methodology. 23(1). 50–50. 17 indexed citations
4.
Andersson‐Hall, Ulrika, Rudolf Kaaks, Matthias B. Schulze, et al.. (2023). Altered plasma metabolite levels can be detected years before a glioma diagnosis. JCI Insight. 8(19). 8 indexed citations
6.
Andersson‐Hall, Ulrika, et al.. (2022). Exercise, aerobic fitness, and muscle strength in relation to glucose tolerance 6 to 10 years after gestational diabetes. Diabetes Research and Clinical Practice. 191. 110078–110078. 1 indexed citations
7.
Andersson‐Hall, Ulrika, Pernilla Svedin, Carina Mallard, et al.. (2021). Growth differentiation factor 15 increases in both cerebrospinal fluid and serum during pregnancy. PLoS ONE. 16(5). e0248980–e0248980. 19 indexed citations
8.
Nielsen, Christel, Ulrika Andersson‐Hall, Christian Lindh, et al.. (2020). Pregnancy-induced changes in serum concentrations of perfluoroalkyl substances and the influence of kidney function. Environmental Health. 19(1). 80–80. 33 indexed citations
9.
Andersson‐Hall, Ulrika, et al.. (2020). Body Composition During Pregnancy: Longitudinal Changes and Method Comparisons. Reproductive Sciences. 27(7). 1477–1489. 13 indexed citations
10.
Andersen, Emil, Ali Altıntaş, Ulrika Andersson‐Hall, Agneta Holmäng, & Romain Barrès. (2019). Environmental Factors Influence the Epigenetic Signature of Newborns from Mothers with Gestational Diabetes. Epigenomics. 11(8). 861–873. 7 indexed citations
11.
Chorell, Elin, Ulrika Andersson‐Hall, Kerstin Berntorp, et al.. (2017). Pregnancy to postpartum transition of serum metabolites in women with gestational diabetes. Metabolism. 72. 27–36. 23 indexed citations
12.
Hansen, Mette, Jens Bangsbo, Jørgen Jensen, et al.. (2016). Protein intake during training sessions has no effect on performance and recovery during a strenuous training camp for elite cyclists. Journal of the International Society of Sports Nutrition. 13(1). 9–9. 28 indexed citations
13.
Papp, Robert, Ulrika Andersson‐Hall, & Louis‐David Cantin. (2013). Evaluating MISER chromatography for a rapid formulation screen. Journal of Pharmaceutical and Biomedical Analysis. 77. 94–99. 12 indexed citations
14.
Platt, Frances M., Mylvaganam Jeyakumar, Ulrika Andersson‐Hall, Raymond A. Dwek, & Terry D. Butters. (2005). New Developments in Treating Glycosphingolipid Storage Diseases. Advances in experimental medicine and biology. 564. 117–126. 12 indexed citations
15.
Andersson‐Hall, Ulrika, David A. Smith, Mylvaganam Jeyakumar, et al.. (2004). Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease. Neurobiology of Disease. 16(3). 506–515. 62 indexed citations
16.
Andersson‐Hall, Ulrika, Karin Filipsson, Caroline R. Abbott, et al.. (2004). AMP-activated Protein Kinase Plays a Role in the Control of Food Intake. Journal of Biological Chemistry. 279(13). 12005–12008. 610 indexed citations breakdown →
17.
Andersson‐Hall, Ulrika, Gabriele Reinkensmeier, Terry D. Butters, Raymond A. Dwek, & Frances M. Platt. (2003). Inhibition of glycogen breakdown by imino sugars in vitro and in vivo. Biochemical Pharmacology. 67(4). 697–705. 20 indexed citations
18.
Wing, D. R., Brett Garner, Gabriele Reinkensmeier, et al.. (2001). High-Performance Liquid Chromatography Analysis of Ganglioside Carbohydrates at the Picomole Level after Ceramide Glycanase Digestion and Fluorescent Labeling with 2-Aminobenzamide. Analytical Biochemistry. 298(2). 207–217. 52 indexed citations
19.
Andersson‐Hall, Ulrika, Terry D. Butters, Raymond A. Dwek, & Frances M. Platt. (2000). N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo. Biochemical Pharmacology. 59(7). 821–829. 120 indexed citations
20.
Andersson‐Hall, Ulrika, Brendan Leighton, Martin E. Young, Eva Blomstrand, & Eric A. Newsholme. (1998). Inactivation of Aconitase and Oxoglutarate Dehydrogenase in Skeletal Musclein Vitroby Superoxide Anions and/or Nitric Oxide. Biochemical and Biophysical Research Communications. 249(2). 512–516. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026